The current accumulated knowledge of the biochemical properties of the A2AR-D2R heteromer offer new therapeutic possibilities for Parkinson’s disease, schizophrenia, SUD and other neuropsychiatric disorders with dysfunction of dorsal or ventral striatopallidal neurons. This evidence concerns the gene DRD2 and Parkinson disease.